Recurrence of Biliary Drug Lithiasis Due to Dipyridamole

D. Sautereau; C. Moesch; J.-C. Letard; F. Cessot; A. Gainant; B. Pillegand

doi:10.1055/s-2007-1004228

Subscribe to RSS

Please copy the URL and add it into your RSS Feed Reader.

https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00000012.xml

Share / Bookmark

Facebook X Linkedin Weibo

Download PDF

Endoscopy 1997; 29(5): 421-423
DOI: 10.1055/s-2007-1004228

Case Report

Recurrence of Biliary Drug Lithiasis Due to Dipyridamole

D. Sautereau¹ , C. Moesch² , J.-C. Letard¹ , F. Cessot¹ , A. Gainant¹ , B. Pillegand¹

¹Dept. of Gastroenterology, Centre Hospitalier Régional Universitaire Dupuytren, Limoges, France
²Dept. of Hygiene, Faculty of Pharmacy, University of Limoges, Limoges, France

Further Information

Publication History

Publication Date:
17 March 2008 (online)

Also available at

PDF Download Permissions and Reprints

Abstract

The occurrence of drug-containing gallstones is not often observed. To our knowledge, three drugs have so far been incriminated-ceftriaxone, glaphenine, and dipyridamole. This report presents the case of an 85-year-old woman who developed a recurrent drug-containing gallstone caused by dipyridamole eighteen months after a previous stone had been removed endoscopically.

>